A Population‐Level Validation of the New 9th Edition of the American Joint Commission on Cancer Staging System for Anal Squamous Cell Carcinoma
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.27926 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Aos Karim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Colon & Rectal Surgery, Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Anus Neoplasms, Carcinoma, Squamous Cell, Neoplasm Staging. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Funding for this project was provided through institutional funds from the University of Minnesota., University of Minnesota.
Abstract (Originalsprache)
Background and Objectives The staging system for anal squamous cell carcinoma (ASCC) was recently revised, downstaging selected node‐positive patients and upstaging some with larger tumors. We aimed to validate this staging system using a population‐based cohort.
Methods
The Surveillance, Epidemiology, and End Results database was analyzed to identify adult ASCC patients. Patients were staged according to the American Joint Committee on Cancer (AJCC) 8th and 9th edition systems. Survival probabilities were estimated using Kaplan‐Meier curves. Cox regression models were utilized to estimate the effect of stage on overall (OS) and cancer‐specific survival (CSS).
Results
A total of 2117 patients were identified and staged based on the two AJCC classifications. At 24 months when comparing stage IIB versus stage IIIA, the 8th edition revealed an improved OS (79% vs. 88%) and CSS (84% vs. 91%) for stage IIIA disease, while the 9th edition restored the hierarchical OS (IIB 88% vs. IIIA 78%) and CSS (91% vs. 82%) order.
Conclusions
The hierarchical increase of the OS HRs, and nearly all CSS HRs, across disease stages validated the updated edition of the AJCC classification. Although this change may not have significant implication on the management of ASCC, it does provide better prognostication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Colon & Rectal Surgery, Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
- Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa, USA.
- Colon & Rectal Surgery Associates, Minneapolis, Minnesota, USA.
- Department of Surgery, University of Iowa, Iowa City, Iowa, USA.
Förderung
- Funding for this project was provided through institutional funds from the University of Minnesota.
- University of Minnesota
Zitieren
APA
Karim, A., Troester, A., Mott, S. L., Arsoniadis, E., Jensen, C., Hassan, I., Kandagatla, P., & Goffredo, P. (2025). A Population‐Level Validation of the New 9th Edition of the American Joint Commission on Cancer Staging System for Anal Squamous Cell Carcinoma. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27926
Vancouver
Karim A, Troester A, Mott SL, Arsoniadis E, Jensen C, Hassan I, et al. A Population‐Level Validation of the New 9th Edition of the American Joint Commission on Cancer Staging System for Anal Squamous Cell Carcinoma. Journal of Surgical Oncology. 2025. doi:10.1002/jso.27926
BibTeX
@article{Karim2025,
author = {Karim, Aos and Troester, Alexander and Mott, Sarah L and Arsoniadis, Elliot and Jensen, Christine and Hassan, Imran and Kandagatla, Pridvi and Goffredo, Paolo},
title = {A Population‐Level Validation of the New 9th Edition of the American Joint Commission on Cancer Staging System for Anal Squamous Cell Carcinoma},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.27926}
}
EUVIMED